CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Rocuroniumdrug
Likely dose
Rocuronium 0.6 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03857750
NCT03857750N/ACompleted

An Observational Study of Rocuronium 0.6 mg/kg Comparing Onset Time, Duration of Action and Effect on Intubation Conditions in Younger (18 - 40 Years) and Elderly Patients (> 80 Years)

Rigshospitalet, Denmark·observational·Posted Feb 28, 2019·Updated Jun 2, 2020

In Brief

An observational study evaluating Rocuronium for Elective Surgery. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The number of elderly patients (\>80 years) is increasing and a large proportion of these patients will require surgery and anaestheasia within the next decades. During anaesthesia NMBAs are used to facilitate tracheal intubation, from former studies it is reported that elderly patients are more sensitive towards muscle relaxants. It is unknown if there are differences in onset times of NMBAs between younger patients and elderly. The aim of this study is to determine the onset time, duration of action and effect on intubating conditions for rocuronium 0.6 mg/kg in patients aged 18-40 years and in patiens \>80 years. The hypothesis of this study is that rocuronium administered in elderly patients (\>80 years) has a longer onset time compared to younger patients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesDenmark
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 28, 2019
Enrollment StartMar 27, 2019
Primary CompletionOct 8, 2019
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.3 years ago

Interventions

Rocuroniumdrug

0.6 mg/kg